SPS
PRCT icon

Susquehanna Portfolio Strategies’s Procept Biorobotics PRCT Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.89M Buy
216,593
+201,578
+1,343% +$5.05M 0.08% 282
2026
Q1 		$376K Buy
+15,015
New +$423K 0.01% 806

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Susquehanna Portfolio Strategies's PRCT Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Procept Biorobotics (PRCT) stake by 1,343% in Q2 2026, buying an estimated $5.05M and bringing the position to 216,593 shares worth $4.89M. The position accounts for 0.08% of the portfolio, ranked #282.

Susquehanna Portfolio Strategies first reported a position in PRCT in Q1 2026 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Susquehanna Portfolio Strategies held 216,593 shares of Procept Biorobotics worth $4.89M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 201,578 Procept Biorobotics shares in Q2 2026, an estimated $5.05M.
  • Procept Biorobotics made up 0.08% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #282 holding.
  • Susquehanna Portfolio Strategies first reported a position in Procept Biorobotics in Q1 2026 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.